Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

Red yeast rice for dyslipidemia in statin-intolerant patients.

Borden WB.

Curr Atheroscler Rep. 2010 Jan;12(1):11-3. doi: 10.1007/s11883-009-0084-9. No abstract available.

PMID:
20425265
[PubMed]
2.

Statin alternatives or just placebo: an objective review of omega-3, red yeast rice and garlic in cardiovascular therapeutics.

Ong HT, Cheah JS.

Chin Med J (Engl). 2008 Aug 20;121(16):1588-94. Review.

PMID:
18982874
[PubMed - indexed for MEDLINE]
Free Article
3.

Red yeast rice: a new hypolipidemic drug.

Journoud M, Jones PJ.

Life Sci. 2004 Apr 16;74(22):2675-83. Review.

PMID:
15069955
[PubMed - indexed for MEDLINE]
4.

Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.

Fazio S.

Clin Ther. 2008 Feb;30(2):294-306. doi: 10.1016/j.clinthera.2008.02.004. Review.

PMID:
18343268
[PubMed - indexed for MEDLINE]
5.

Complementary and alternative therapies for the management of dyslipidemia.

Nies LK, Cymbala AA, Kasten SL, Lamprecht DG, Olson KL.

Ann Pharmacother. 2006 Nov;40(11):1984-92. Epub 2006 Oct 17. Review.

PMID:
17047144
[PubMed - indexed for MEDLINE]
6.

[With red rice against cholesterol?].

Enkovaara AL.

Duodecim. 2010;126(6):623-6. Review. Finnish.

PMID:
20597312
[PubMed - indexed for MEDLINE]
7.

Management of the patient with statin intolerance.

Vandenberg BF, Robinson J.

Curr Atheroscler Rep. 2010 Jan;12(1):48-57. doi: 10.1007/s11883-009-0077-8. Review.

PMID:
20425271
[PubMed - indexed for MEDLINE]
8.

The dyslipidemia of chronic renal disease: effects of statin therapy.

Ozsoy RC, van Leuven SI, Kastelein JJ, Arisz L, Koopman MG.

Curr Opin Lipidol. 2006 Dec;17(6):659-66. Review.

PMID:
17095911
[PubMed - indexed for MEDLINE]
9.

Red yeast rice.

[No authors listed]

Med Lett Drugs Ther. 2009 Sep 7;51(1320):71-2. Review.

PMID:
19738551
[PubMed - indexed for MEDLINE]
10.

Targeting cardiovascular risk in patients with diabetes: management of dyslipidemia.

Ali YS, Linton MF, Fazio S.

Curr Opin Endocrinol Diabetes Obes. 2008 Apr;15(2):142-6. doi: 10.1097/MED.0b013e3282f5ff98. Review.

PMID:
18316949
[PubMed - indexed for MEDLINE]
11.

The influence of statins on the expansion rate and rupture risk of abdominal aortic aneurysms.

VAN KUIJK JP, FLU WJ, WITTEVEEN OP, VOUTE M, BAX JJ, POLDERMANS D.

J Cardiovasc Surg (Torino). 2009 Oct;50(5):599-609. Review.

PMID:
19741575
[PubMed - indexed for MEDLINE]
12.

Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence.

Kanbay M, Turgut F, Covic A, Goldsmith D.

J Nephrol. 2009 Sep-Oct;22(5):598-609. Review.

PMID:
19809992
[PubMed - indexed for MEDLINE]
14.

A neuromuscular approach to statin-related myotoxicity.

Baker SK, Samjoo IA.

Can J Neurol Sci. 2008 Mar;35(1):8-21. Review.

PMID:
18380273
[PubMed - indexed for MEDLINE]
15.

The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.

Harper CR, Jacobson TA.

Curr Opin Lipidol. 2007 Aug;18(4):401-8. Review.

PMID:
17620856
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk